ReviewNeuro-oncology advances

A systematic review of the utility of amino acid PET in assessing treatment response to bevacizumab in recurrent high-grade glioma.

Kendall L Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.